7TUG | pdb_00007tug

Crystal structure of Tapasin in complex with PaSta2-Fab


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.90 Å
  • R-Value Free: 
    0.332 (Depositor), 0.323 (DCC) 
  • R-Value Work: 
    0.282 (Depositor), 0.282 (DCC) 
  • R-Value Observed: 
    0.285 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 7TUG

Ligand Structure Quality Assessment 


This is version 1.3 of the entry. See complete history

Literature

Structural mechanism of tapasin-mediated MHC-I peptide loading in antigen presentation.

Jiang, J.Taylor, D.K.Kim, E.J.Boyd, L.F.Ahmad, J.Mage, M.G.Truong, H.V.Woodward, C.H.Sgourakis, N.G.Cresswell, P.Margulies, D.H.Natarajan, K.

(2022) Nat Commun 13: 5470-5470

  • DOI: https://doi.org/10.1038/s41467-022-33153-8
  • Primary Citation Related Structures: 
    7TUC, 7TUD, 7TUE, 7TUF, 7TUG, 7TUH

  • PubMed Abstract: 

    Loading of MHC-I molecules with peptide by the catalytic chaperone tapasin in the peptide loading complex plays a critical role in antigen presentation and immune recognition. Mechanistic insight has been hampered by the lack of detailed structural information concerning tapasin-MHC-I. We present here crystal structures of human tapasin complexed with the MHC-I molecule HLA-B*44:05, and with each of two anti-tapasin antibodies. The tapasin-stabilized peptide-receptive state of HLA-B*44:05 is characterized by distortion of the peptide binding groove and destabilization of the β 2 -microglobulin interaction, leading to release of peptide. Movements of the membrane proximal Ig-like domains of tapasin, HLA-B*44:05, and β 2 -microglobulin accompany the transition to a peptide-receptive state. Together this ensemble of crystal structures provides insights into a distinct mechanism of tapasin-mediated peptide exchange.


  • Organizational Affiliation
    • Molecular Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892-1892, USA.

Macromolecule Content 

  • Total Structure Weight: 94.03 kDa 
  • Atom Count: 5,304 
  • Modeled Residue Count: 752 
  • Deposited Residue Count: 866 
  • Unique protein chains: 3

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
TapasinA [auth D]416Homo sapiensMutation(s): 0 
Gene Names: TAPBPNGS17TAPA
UniProt & NIH Common Fund Data Resources
Find proteins for O15533 (Homo sapiens)
Explore O15533 
Go to UniProtKB:  O15533
PHAROS:  O15533
GTEx:  ENSG00000231925 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupO15533
Glycosylation
Glycosylation Sites: 1Go to GlyGen: O15533-1
Sequence Annotations
Expand
Reference Sequence
Find similar proteins by:|  3D Structure
Entity ID: 2
MoleculeChains  Sequence LengthOrganismDetailsImage
PaSta2 Fab heavy chainB [auth H]230Mus musculusMutation(s): 0 
Find similar proteins by:|  3D Structure
Entity ID: 3
MoleculeChains  Sequence LengthOrganismDetailsImage
PaSta2 Fab kappa light chainC [auth L]220Mus musculusMutation(s): 0 

Small Molecules

Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
NAG

Query on NAG



Download:Ideal Coordinates CCD File
D
2-acetamido-2-deoxy-beta-D-glucopyranose
C8 H15 N O6
OVRNDRQMDRJTHS-FMDGEEDCSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.90 Å
  • R-Value Free:  0.332 (Depositor), 0.323 (DCC) 
  • R-Value Work:  0.282 (Depositor), 0.282 (DCC) 
  • R-Value Observed: 0.285 (Depositor) 
Space Group: C 2 2 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 101.09α = 90
b = 168.82β = 90
c = 108.66γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
XDSdata reduction
XSCALEdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)United States--

Revision History  (Full details and data files)

  • Version 1.0: 2022-09-07
    Type: Initial release
  • Version 1.1: 2022-09-28
    Changes: Database references
  • Version 1.2: 2023-10-18
    Changes: Data collection, Refinement description
  • Version 1.3: 2024-11-13
    Changes: Structure summary